Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms ...
The response to fraud is not to shut down Education Savings Accounts programs, but to punish bad actors, provide transparency ...
Immune thrombocytopenia (ITP) is a disorder of increased platelet destruction and reduced platelet production and is associated with an increased bleeding risk and a compromised quality of life.
Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference PARIS and CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company” ...
Data validate the efficacy, safety, and tolerability of elismetrep, an investigational first-in-class TRPM8 ...
Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A ...
TME Pharma Announces Publication of NOX-A12 'Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications ...
The Pennsylvania Department of Aging (PDA) this week brought together 200 volunteers and staff from Pennsylvania’s 52 Area ...
This is a useful study that seeks to elucidate the molecular mechanisms underlying spinal motor circuit assembly. The authors demonstrate that loss of Onecut transcription factors in spinal motor ...
Label Extension Period Demonstrated Sustained Improvements in Patient-Reported Disease Severity, Cognitive Functioning and ...
Odds of 50 random events happening to you. Millions of Americans buy lottery tickets each year, even though most people know ...
BIDMC-led study finds DASH-based grocery delivery lowers blood pressure and LDL cholesterol in Black adults, improving heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results